Related Experiment Video

Updated: May 28, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Mild cognitive impairment in old age. Diagnostics and prognostic significance]

F M Reischies1, F Wertenauer

  • 1Arbeitsgruppe Neuropsychologie und experimentelle Psychopathologie, Charité - Universitätsmedizin Berlin, Deutschland. friedel.reischies@charite.de

Der Nervenarzt
|October 29, 2011
PubMed

Insights

Diagnosing mild cognitive impairment (MCI) allows for early detection of dementia before irreversible brain changes occur. This facilitates research into slowing or halting dementia progression for better patient outcomes.

Area of Science:

  • Neurology
  • Geriatrics
  • Neuroscience

Background:

  • Clinical dementia research advances enable early diagnosis of prodromal dementia stages.
  • Mild cognitive impairment (MCI) is the primary concept for identifying these early stages.
  • Diagnosing dementia after clinical symptoms appear often means irreversible neuropathological changes are advanced.

Purpose of the Study:

  • To present the concept and diagnostic procedures for mild cognitive impairment (MCI).
  • To highlight the potential for early Alzheimer's disease detection using biomarkers and brain imaging.
  • To advocate for diagnosing dementia disorders at the MCI stage to enable interventions.

Main Methods:

  • Clinical assessment methods.
  • Neuropsychological testing.
  • Laboratory diagnostic procedures, including biomarkers and brain imaging for Alzheimer's disease.

Main Results:

  • Mild cognitive impairment (MCI) serves as a key indicator for prodromal dementia.
  • Biomarkers and brain imaging show promise for detecting preclinical Alzheimer's disease.
  • Early detection at the MCI stage is crucial for potential therapeutic interventions.

Conclusions:

  • Detecting dementia in its mild cognitive impairment (MCI) stage is essential for intervention.
  • Early diagnosis facilitates research aimed at slowing or halting dementia progression.
  • Intervention during the MCI phase may prevent the advancement to a full clinical dementia syndrome.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...